# Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial

> **NCT02258984** · NA · UNKNOWN · sponsor: **Mespere Lifesciences Inc.** · enrollment: 80 (estimated)

## Conditions studied

- Severe Sepsis
- Acute Heart Failure

## Interventions

- **DEVICE:** Mespere Venus 1000 Non-Invasive CVP System

## Key facts

- **NCT ID:** NCT02258984
- **Lead sponsor:** Mespere Lifesciences Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2015-11
- **Final completion:** 2015-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2015-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02258984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02258984, "Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02258984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*